Follow
Dr Juhi Saxena
Dr Juhi Saxena
Assistant Professor, PIT, Parul University
No verified email
Title
Cited by
Cited by
Year
Process optimization for green synthesis of silver nanoparticles by Sclerotinia sclerotiorum MTCC 8785 and evaluation of its antibacterial properties
J Saxena, PK Sharma, MM Sharma, A Singh
SpringerPlus 5, 1-10, 2016
1382016
Plants in anticancer drug discovery: from molecular mechanism to chemoprevention
AJ Siddiqui, S Jahan, R Singh, J Saxena, SA Ashraf, A Khan, ...
BioMed Research International 2022, 2022
862022
Emerging role of fungi in nanoparticle synthesis and their applications
J Saxena, MM Sharma, S Gupta, A Singh
WJPPS 3 (9), 1586-1613, 2014
672014
Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents
K Chauhan, M Sharma, J Saxena, SV Singh, P Trivedi, K Srivastava, ...
European Journal of Medicinal Chemistry, 2013
602013
Quantification of NETs formation in neutrophil and its correlation with the severity of sepsis and organ dysfunction
S Kumar, E Gupta, S Kaushik, VK Srivastava, J Saxena, S Mehta, A Jyoti
Clinica chimica acta 495, 606-610, 2019
502019
Neutrophil extracellular traps and organ dysfunction in sepsis
S Kumar, N Payal, VK Srivastava, S Kaushik, J Saxena, A Jyoti
Clinica Chimica Acta 523, 152-162, 2021
282021
The interplay of oxidative stress and ROS scavenging: antioxidants as a therapeutic potential in sepsis
S Kumar, J Saxena, VK Srivastava, S Kaushik, H Singh, K Abo-EL-Sooud, ...
Vaccines 10 (10), 1575, 2022
242022
Nitrosative stress and cytokines are linked with the severity of sepsis and organ dysfunction
S Kumar, E Gupta, VK Srivastava, S Kaushik, J Saxena, LK Goyal, ...
British Journal of Biomedical Science 76 (1), 29-34, 2019
242019
Therapeutic role and drug delivery potential of neuroinflammation as a target in neurodegenerative disorders
A Singh, A Chokriwal, MM Sharma, D Jain, J Saxena, BJ Stephen
ACS Chemical Neuroscience 8 (8), 1645-1655, 2017
232017
Targeting COPD with PLGA-based nanoparticles: current status and prospects
J Saxena, M Bisen, A Misra, VK Srivastava, S Kaushik, AJ Siddiqui, ...
BioMed Research International 2022, 2022
162022
Biomimetic synthesis of AgNPs from Penicillium chrysogenum strain FGCC/BLS1 by optimising physico-cultural conditions and assessment of their antimicrobial potential
J Saxena, P Sharma, A Singh
IET nanobiotechnology 11 (5), 576-583, 2016
152016
Plant‐associated endophytic fungi as potential bio‐factories for extracellular enzymes: Progress, Challenges and Strain improvement with precision approaches
D Raghav, A Jyoti, AJ Siddiqui, J Saxena
Journal of Applied Microbiology 133 (2), 287-310, 2022
142022
Biogenic synthesis of silver nanoparticles from Aspergillus oryzae mtcc 3107 against plant pathogenic fungi Sclerotinia sclerotiorum mtcc 8785
T Gupta, J Saxena
Journal of microbiology, biotechnology and food sciences 12 (4), e9387-e9387, 2023
92023
Isolation and Characterization of Neutral Proteases Producing Soil fungus Cladosporium sp PAB2014 Strain FGCC/BLS2: Process Optimization for Improved …
J Saxena, N Choudhary, P Gupta, MM Sharma, A Singh
NISCAIR-CSIR, India, 2017
92017
Hunt for Cellulase Producing Fungi from Soil Samples
J Saxena, V Pant, MM Sharma, S Gupta, A Singh
92015
Fast track diagnostic tools for clinical management of sepsis: paradigm shift from conventional to advanced methods
E Gupta, J Saxena, S Kumar, U Sharma, S Rastogi, VK Srivastava, ...
Diagnostics 13 (2), 277, 2023
82023
Preferential targeting of human erythrocytes infected with the malaria parasite Plasmodium falciparum via hexose transporter surface proteins
KD Heikham, A Gupta, A Kumar, C Singh, J Saxena, K Srivastava, SK Puri, ...
International Journal of Pharmaceutics 483 (1-2), 57-62, 2015
82015
Bacteriocin-Nanoconjugates (Bac10307-AgNPs) Biosynthesized from Lactobacillus acidophilus-Derived Bacteriocins Exhibit Enhanced and Promising Biological …
AJ Siddiqui, M Patel, M Adnan, S Jahan, J Saxena, MM Alshahrani, ...
Pharmaceutics 15 (2), 403, 2023
72023
A bioinformatics approach for the prediction of immunogenic properties and structure of the SARS-COV-2 B. 1.617. 1 variant spike protein
VK Srivastava, S Kaushik, G Bhargava, A Jain, J Saxena, A Jyoti
BioMed Research International 2021, 1-8, 2021
72021
A critical review on human malaria and schistosomiasis vaccines: current state, recent advancements, and developments
AJ Siddiqui, J Bhardwaj, J Saxena, S Jahan, M Snoussi, F Bardakci, ...
Vaccines 11 (4), 792, 2023
62023
The system can't perform the operation now. Try again later.
Articles 1–20